Publicaciones en colaboración con investigadores/as de VU University Medical Center (56)

2023

  1. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  2. Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))

    Nature communications

  3. Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 36

  4. Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning

    Genome Medicine, Vol. 15, Núm. 1

  5. Pilot study of a European oncology regimen reference library and matching algorithm

    European Journal of Hospital Pharmacy, Vol. 30, Núm. 4, pp. 227-231

  6. Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits

    Alzheimer's and Dementia, Vol. 19, Núm. 6, pp. 2317-2331

2022

  1. Functional eigenvector centrality dynamics are related to amyloid deposition in preclinical Alzheimer’s Disease

    Alzheimer's and Dementia

  2. Functional eigenvector centrality dynamics are related to amyloid deposition in preclinical Alzheimer’s Disease

    Alzheimer's and Dementia

  3. Predicting AT(N) pathologies in Alzheimer’s disease from blood-based proteomic data using neural networks

    Frontiers in Aging Neuroscience, Vol. 14

  4. Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation

    Molecular Psychiatry, Vol. 27, Núm. 4, pp. 1990-1999

2021

  1. Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia

    Alzheimer's and Dementia, Vol. 17, Núm. 3, pp. 500-514

  2. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Nature communications, Vol. 12, Núm. 1, pp. 3417

  3. Differential early subcortical involvement in genetic FTD within the GENFI cohort

    NeuroImage: Clinical, Vol. 30

  4. Disease-related cortical thinning in presymptomatic granulin mutation carriers

    NeuroImage: Clinical, Vol. 29

  5. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

    eLife, Vol. 10

  6. MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 92, Núm. 6, pp. 608-616

  7. Plasma Proteomic Biomarkers Relating to Alzheimer’s Disease: A Meta-Analysis Based on Our Own Studies

    Frontiers in Aging Neuroscience, Vol. 13

  8. Replication study of plasma proteins relating to Alzheimer's pathology

    Alzheimer's and Dementia, Vol. 17, Núm. 9, pp. 1452-1464

  9. Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE Study

    CNS Drugs, Vol. 35, Núm. 9, pp. 1009-1022

  10. Sex-specific metabolic pathways were associated with alzheimer’s disease (Ad) endophenotypes in the european medical information framework for ad multimodal biomarker discovery cohort

    Biomedicines, Vol. 9, Núm. 11